Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

Stopped early · Not applicable

Conditions studied: Prostate Cancer, Elevated Prostate Specific Antigen (PSA)

In brief

This is a prospective, serum proteomics study of men who are to undergo prostate biopsy. The purpose is to determine if proteomic profiles can be used to distinguish between men with prostate cancer on biopsy from men with no cancer on biopsy.

Key facts

Study ID
NCT00773773
Run by
Memorial Sloan Kettering Cancer Center
People needed
58
Starts
2008-10-14
Expected to finish
2024-03-08
Last updated by the study team
2024-09-04

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.